argenx announces presentation of updated ARGX-110 phase 1 data in TCL at EHA 2016
June 10, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Breda, the Netherlands / Ghent,...
argenx successfully closes €30 million private placement
June 03, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
NOT FOR RELEASE, PUBLICATION OR...
argenx announces efficacy and expanded safety data from Phase 1 trial of ARGX-111
June 03, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
...
argenx announces private placement of 2,703,000 new shares for an aggregate amount of €30 million with institutional investors
June 01, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
NOT FOR RELEASE, PUBLICATION OR...
argenx Reports First Quarter 2016 Financial Results and Provides Business Update
May 11, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Breda, the Netherlands / Ghent,...
argenx announces results of Annual General Meeting 2016
April 28, 2016 05:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Breda, the Netherlands / Ghent, Belgium...
argenx and AbbVie to Collaborate on ARGX-115 Against Novel Immuno-Oncology Target
April 21, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
--argenx Management to Discuss...
argenx announces Annual General Meeting of Shareholders 28 April 2016
March 16, 2016 12:45 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Breda, the Netherlands - arGEN-X N.V....
argenx's Partner Bird Rock Bio Demonstrates Potential for Gerilimzumab, A Novel SIMPLE Antibody(TM) Against IL-6 to Treat Rheumatoid Arthritis
March 16, 2016 03:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Breda, the Netherlands / Ghent,...
argenx reports fourth quarter business update and full year 2015 financial results
March 11, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Clinical programs in severe auto-immune...